MAPK3 and glioblastoma: Using F3.EGFRviii CNSCs model, we demonstrated LAMTOR3 in GBM served as an important signaling mediator to control MEK1/ERK1/2 pathway, of which activation contributed to maintaining ‘neural cancer stemness’.